Skip to main content

Research Repository

Advanced Search

All Outputs (63)

Does clinical method mask significant VTE-related mortality and morbidity in malignant disease? Mini review. (2009)
Journal Article
Johnson, M., & Maraveyas, A. (2009). Does clinical method mask significant VTE-related mortality and morbidity in malignant disease? Mini review. The British Journal of Cancer, 100(12), 1837 - 1841. https://doi.org/10.1038/sj.bjc.6605091

After more than 150 years of a recognised link between cancer and vascular thromboembolic events (VTE), and despite a greatly improved understanding of its pathophysiology, epidemiology and treatment, the management of patients with cancer and VTE is... Read More about Does clinical method mask significant VTE-related mortality and morbidity in malignant disease? Mini review..

Does clinical method mask significant VTE-related mortality and morbidity in malignant disease? (2009)
Journal Article
Johnson, M., & Maraveyas, A. (2009). Does clinical method mask significant VTE-related mortality and morbidity in malignant disease?. The British Journal of Cancer, 100(12), 1837-1841. https://doi.org/10.1038/sj.bjc.6605091

After more than 150 years of a recognised link between cancer and vascular thromboembolic events (VTE), and despite a greatly improved understanding of its pathophysiology, epidemiology and treatment, the management of patients with cancer and VTE is... Read More about Does clinical method mask significant VTE-related mortality and morbidity in malignant disease?.

Radioimmunotherapy of ovarian cancer (1995)
Book Chapter
Maraveyas, A., & Epenetos, A. A. (1995). Radioimmunotherapy of ovarian cancer. In D. M. Goldenberg (Ed.), Cancer Therapy with Radiolabeled Antibodies (155-172). CRC Press. https://doi.org/10.1201/9781351070409-12

Ovarian cancer is the most lethal of gynecological cancers. It presents with clinical symptoms usually at an advanced stage, when intervention and treatment are unsatisfactory. Patients usually die of uncontrolled locoregional intraperitoneal spread... Read More about Radioimmunotherapy of ovarian cancer.